Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Hikma Pharmaceuticals Ord Shs HKMPF

Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products... see more

Recent & Breaking News (OTCPK:HKMPF)

Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home

PR Newswire May 29, 2019

Hikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation

PR Newswire May 2, 2019

Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP

PR Newswire May 1, 2019

Hikma Demonstrates Support for US Pharmacists and Patient Safety

Business Wire November 30, 2018

Hikma Pharmaceuticals Appoints Kristy Ronco Executive Vice President, Sales and Marketing, Generics

Business Wire August 16, 2018

Hikma Acts to Ease Critical Shortage of Pain Medications Needed by US Hospitals and Their Patients

Business Wire July 18, 2018

Propeller Health Publishes Results From a Large Public Health Study on Asthma; Successfully Reduces the Burden of Asthma in Louisville

PR Newswire April 2, 2018

Propeller Health Achieves ISO 13485 Medical Device Quality Certification

PR Newswire February 8, 2018

Propeller Health Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

PR Newswire December 20, 2017

Propeller Health and Express Scripts Partnership Offers Innovative Digital Respiratory Care to Improve Health for People with Asthma or COPD

PR Newswire November 16, 2017

Propeller Health launches Air - a free service to inform people of asthma conditions in their area

PR Newswire October 10, 2017

Propeller Health presents data on asthma and COPD at the European Respiratory Society International Congress

PR Newswire September 19, 2017

Propeller Health Announces Expansion of Digital Health Collaboration with GlaxoSmithKline to Improve Management of Asthma and COPD

PR Newswire August 24, 2017

Hikma Announces Expanded Licensing Agreement with Takeda for New Products in the Middle East and North Africa

PR Newswire Europe Non Regulatory August 17, 2017

UBS Likes The Tune Of Jazz Pharma's Settlement With Hikma

Benzinga.com  April 6, 2017

Propeller Health Enters into Collaboration to Connect Breezhaler™ Devices to the Propeller Platform

PR Newswire February 8, 2017

Propeller and MIR Announce License Agreement and Collaboration to Integrate Mobile and Clinic-Based Spirometers into the Propeller Platform

PR Newswire December 1, 2016

Propeller Health Receives FDA Clearance for the Propeller Platform in Association with GSK's Ellipta® Inhaler

PR Newswire November 7, 2016

Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy

PR Newswire October 20, 2016

Hikma Founder and Honorary Life President Samih Darwazah Passes Away

PR Newswire May 18, 2015